arrow
L

LyndLarryD

H指数:0
被引数:0

个人简介

"Dr. Larry Lynd received his BSP in 1986 from the University of Saskatchewan and his PhD in the Department of Health Care and Epidemiology at UBC in 2002. He then completed a two-year post-doctoral fellowship in health economics with Dr. Bernie O'Brien at McMaster University. Currently, Dr. Lynd is a professor and director of the Collaboration for Outcomes Research and Evaluation (CORE) at the UBC Faculty of Pharmaceutical Sciences, scientist at the Centre for Clinical Epidemiology and Evaluation, scientist at the Centre for Health Evaluation and Outcomes Sciences, scholar at the Peter Wall Institute of Advanced Studies, and associate of the UBC School of Population and Public Health. Dr. Lynd has made significant contributions serving on a number of committees, including chair of the Health Canada Special Advisory Committee on Non-Prescription Drugs, Special Advisory Committee to the Respiratory and Allergy Therapies Division of Health Canada, BC Ministry of Health Services Expensive Drugs for Rare Diseases Committee, and the BC PharmaNet Data Stewardship Committee."

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

暂无数据

研究方向

Dr. Lynd conducts state of the art outcomes research and epidemiologic studies including cost-effectiveness analysis and therapeutic risk benefit analysis. Through his involvement in the BC Ministry of Health Expensive Drug for Rare Diseases Committee, to which he was appointed for a second term for his health economics expertise, he has identified significant knowledge gaps relating to policy and decision-making associated with orphan drugs and personalized medicine. As such, he was successful in receiving a Canadian Institutes of Health Research team grant as the principal investigator for a national, multi-disciplinary team of economists, epidemiologists, policy researchers, ethicists, lawyers, clinicians, and knowledge users to develop new knowledge relating to funding and reimbursement of expensive drugs for rare diseases. One of Dr. Lynd's primary areas of interest is in respiratory diseases, specifically asthma and chronic obstructive pulmonary disease. Because the evaluation of health outcomes has no geographic or disease-specific boundaries, he is also involved in a number of international studies that have the potential to influence policy in countries such as Rwanda and Cambodia. Overall, the ultimate research goal for Dr. Lynd is the translation of knowledge into improved patient outcomes and the health care decision-making process.
暂无数据